Life Sciences & Medtech

Markets We Serve

• Biopharma

Increasing complexity, rapid innovation, and an explosion in promising new treatment modalities are challenging business models, as pressure continues to mount from reimbursement challenges and commercial competition.

• Medtech

Digital capability is driving a shift from products to solutions, while global and regional players contend with growing competition and decreasing innovation headroom.

• Generics and Biosimilars

New business models and go-to-market strategies are priorities amid incessant competitive pressure.

• Consumer and Digital Health

The digital transformation of retail and consumer health experiences has upended the industry, creating both threats and opportunities.

• Life Sciences Tools and Services

Technology is disrupting services, challenging providers and distributors of lab and testing products, as tests get smaller, are increasingly done on-site, and business models change.

Strategy Development

We work with companies to navigate shifts in the medical ecosystem, tailoring growth strategies that address disruption caused by transformational technologies, new business models, non-traditional competition, and regulatory change. We help clients anticipate shifts in markets, assess their business lines, and develop transformation strategies. We guide them through design and deployment of new operating models that support multiple types of innovation simultaneously, and help develop new lines of business, ventures, partnerships, and opportunities for growth.

We leverage core concepts developed at Innosight, including our “future back” and dual transformation methods. Future back is a disciplined and rigorous way to push beyond typical planning horizons, identify threats and opportunities, and convert goals into strategy. For companies pursuing a transformation agenda, dual transformation helps to reposition the core business while developing new platforms for growth.

New Growth Platform Development

We work with leading medtech and life science companies to develop smart diversification strategies, reflecting insights into product and service innovation, market segmentation, and geographical reach. When ambitions include entering new markets and geographies, we help create conditions for success through the design of innovative business and operating models, exploring a range of mechanisms from acquisitions to strategic partnerships.

As healthcare providers increasingly move to digital platforms, they can make the most of technology spending by ensuring investments are integrated into their overall business strategy. We help organizations develop digital strategies, implementing analytics and automation while building platforms that better serve customers and open doors to new opportunities.

Business Model Innovation

We help companies understand, anticipate, and act on business model shifts that impact how value is created, captured, and delivered, such as the shift to new pricing models in pharma and the move from selling products to solutions that embed services and digital elements in medtech. We support clients through creative and disciplined business model innovation processes, moving from customer insights to business model blueprint to emergent test-and-learn plans.

R&D Performance and Capabilities

With innovation in life sciences and medtech growing increasingly complex, companies must improve R&D performance, from optimizing portfolios to leveraging digital and AI to ensuring there is the right infrastructure of talent and technology in place to drive productivity. We offer expertise in helping organizations enhance their R&D capabilities to create greater value as they transition from product supplier to orchestrator of patient-centric solutions. This includes exploring new portfolio models and venture partnerships to pursue breakthrough research and therapies.

Leadership, People, and Culture

We help organizations stay vibrant in the fast-changing life sciences ecosystem, developing people strategies and leadership trainings to promote employee agility, including efforts to integrate teams after mergers and acquisitions. We have particular expertise in developing holistic culture change management programs that embed new employee behaviors and increase resilience. We also design leadership development programs that help teams embrace a disruptive future.

Our approach is based on groundbreaking research on habit and behavioral change that recognizes successful innovation requires new employee and leader mindsets, which is especially relevant in life sciences where innovation is core to the culture.